Skip to main content
. Author manuscript; available in PMC: 2014 Jan 16.
Published in final edited form as: Circulation. 2012 Mar 5;125(15):1928–1952. doi: 10.1161/CIR.0b013e31824f2173

Table 4.

Triggers for Formally Assessing Prognosis and Having Conversations About Goals of Care and Voluntary Advance Care Planning

  • Routine

    • “Annual Heart Failure Review” with a scheduled clinic visit

  • Event-driven “milestones” that should prompt reassessment

    • Increased symptom burden and/or decreased quality of life

    • Significant decrease in functional capacity

      • Loss of ADLs

      • Falls

      • Transition in living situation (independent to assisted or LTC)

    • Worsening heart failure prompting hospitalization, particularly if recurrent57

    • Serial increases of maintenance diuretic dose

    • Symptomatic hypotension, azotemia, or refractory fluid retention necessitating neurohormonal medication underdosing or withdrawal58

      • Circulatory-renal limitations to ACEI/ARB

      • Decrease or discontinuation of β-blockers because of hypotension

    • First or recurrent ICD shock for VT/VF59

    • Initiation of intravenous inotropic support

    • Consideration of renal replacement therapy

    • Other important comorbidities: new cancer, etc

    • Major “life events”: death of a spouse

ADL indicates activities of daily living; LTC, long-term care; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; ICD, implantable cardioverter-defibrillator; VT, ventricular tachycardia; and VF, ventricular fibrillation.